Reversed Septal Curvature Is Associated with Elevated Troponin Level in Hypertrophic Cardiomyopathy

Renata Rajtar-Salwa1, Tomasz Tokarek1, Paweł Petkow Dimitrow2

  • 1Department of Cardiology and Cardiovascular Interventions, University Hospital, Jakubowskiego 2 St., 30-688 Krakow, Poland.

Disease Markers
|December 23, 2020
PubMed

Insights

Reversed septal curvature (RSC) in hypertrophic cardiomyopathy patients is linked to higher high-sensitivity troponin I (hs-TnI) levels and increased provocable left ventricular outflow tract gradient (LVOTG). This suggests RSC may indicate a higher risk of ischemic events.

Area of Science:

  • Cardiology
  • Echocardiography
  • Biomarkers

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Septal configuration is a key echocardiographic feature in HCM.
  • The clinical significance of reversed septal curvature (RSC) in HCM requires further elucidation.

Purpose of the Study:

  • To compare clinical and echocardiographic parameters in HCM patients stratified by septal configuration.
  • To investigate the association between reversed septal curvature (RSC) and biomarkers like hs-TnI and NT-proBNP.
  • To assess the relationship between RSC and left ventricular outflow tract gradient (LVOTG).

Main Methods:

  • Retrospective analysis of 56 consecutive hypertrophic cardiomyopathy patients.
  • Classification into reversed septal curvature (RSC) and non-RSC groups based on 4-chamber apical window views.
  • Comparison of high-sensitivity troponin I (hs-TnI), NT-proBNP, and provocable left ventricular outflow tract gradient (LVOTG) between groups.

Main Results:

  • Patients with RSC exhibited significantly higher levels of hs-TnI (p=0.001).
  • A trend towards increased NT-proBNP was observed in the RSC group (p=0.056).
  • Provocable LVOTG was significantly higher in patients with RSC (p=0.04), alongside prognostically unfavorable septal thickness.

Conclusions:

  • Reversed septal curvature (RSC) in hypertrophic cardiomyopathy is associated with elevated hs-TnI levels.
  • RSC may serve as a marker for increased risk of ischemic events in HCM patients.
  • Provocable LVOTG is a significant finding in patients with RSC.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
164
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
231
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
208
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
92
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
232
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
169